Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -585 | -256 | -175 |
| Accounts receivable | 4 | N/A | N/A |
| Accounts payable and accrued liabilities | 85 | 166 | N/A |
| Other Working Capital | -5 | 101 | 23 |
| Other Operating Activity | -43 | -146 | 1 |
| Operating Cash Flow | $-545 | $-135 | $-151 |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 0 | 0 | 3,176 |
| Financing Cash Flow | $N/A | $N/A | $3,176 |
| Beginning Cash Position | 3,025 | 3,025 | 0 |
| End Cash Position | 2,480 | 2,890 | 3,025 |
| Net Cash Flow | $-545 | $-135 | $3,025 |
| Free Cash Flow | |||
| Operating Cash Flow | -545 | -135 | -151 |
| Free Cash Flow | -545 | -135 | -151 |